| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Ageism: a social determinant of health that has come of age
|
Mikton, Christopher
|
|
|
397 |
10282 |
p. 1333-1334
|
artikel
|
| 2 |
Assessing government responsibility for COVID-19 deaths
|
Mundt, Adrian P
|
|
|
397 |
10282 |
p. 1345
|
artikel
|
| 3 |
Bart Jacobs
|
Watts, Geoff
|
|
|
397 |
10282 |
p. 1344
|
artikel
|
| 4 |
Bilateral elongated styloid processes: Eagle syndrome
|
Sigdel, Brihaspati
|
|
|
397 |
10282 |
p. 1387
|
artikel
|
| 5 |
Calls for transparency after SARS-CoV-2 origins report
|
Zarocostas, John
|
|
|
397 |
10282 |
p. 1335
|
artikel
|
| 6 |
2021 Canada Gairdner Awards announced
|
Burki, Talha
|
|
|
397 |
10282 |
p. 1337-1338
|
artikel
|
| 7 |
China's response to COVID-19: a chance for collaboration
|
The Lancet,
|
|
|
397 |
10282 |
p. 1325
|
artikel
|
| 8 |
Considering gender-based violence in vaccine prioritisation strategies
|
Chandan, Joht Singh
|
|
|
397 |
10282 |
p. 1345
|
artikel
|
| 9 |
COVID-19 vaccines in high-risk ethnic groups
|
D'Souza, Rashmi S
|
|
|
397 |
10282 |
p. 1348
|
artikel
|
| 10 |
Department of Error
|
|
|
|
397 |
10282 |
p. 1350
|
artikel
|
| 11 |
Department of Error
|
|
|
|
397 |
10282 |
p. 1350
|
artikel
|
| 12 |
Donna Kinnair: campaigning for the real value of nursing
|
Prasad, Aarathi
|
|
|
397 |
10282 |
p. 1339
|
artikel
|
| 13 |
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
|
Emary, Katherine R W
|
|
|
397 |
10282 |
p. 1351-1362
|
artikel
|
| 14 |
Leveraging data and new digital tools to prepare for the next pandemic
|
Davies, Sally C
|
|
|
397 |
10282 |
p. 1349-1350
|
artikel
|
| 15 |
Maternal and child undernutrition: progress hinges on supporting women and more implementation research
|
Shekar, Meera
|
|
|
397 |
10282 |
p. 1329-1331
|
artikel
|
| 16 |
Mobilising evidence, data, and resources to achieve global maternal and child undernutrition targets and the Sustainable Development Goals: an agenda for action
|
Heidkamp, Rebecca A
|
|
|
397 |
10282 |
p. 1400-1418
|
artikel
|
| 17 |
New COVID-19 resurgence in the WHO Eastern Mediterranean region
|
Nabeth, Pierre
|
|
|
397 |
10282 |
p. 1348-1349
|
artikel
|
| 18 |
Newer versus older antiseizure medications: further forward?
|
Cross, J Helen
|
|
|
397 |
10282 |
p. 1327-1329
|
artikel
|
| 19 |
Pandemic moves and countermoves: vaccines and viral variants
|
Sanders, Rogier W
|
|
|
397 |
10282 |
p. 1326-1327
|
artikel
|
| 20 |
Racism is the public health crisis
|
Andrews, Kehinde
|
|
|
397 |
10282 |
p. 1342-1343
|
artikel
|
| 21 |
Rapid identification and tracking of SARS-CoV-2 variants of concern
|
Chakraborty, Debojyoti
|
|
|
397 |
10282 |
p. 1346-1347
|
artikel
|
| 22 |
Revisiting maternal and child undernutrition in low-income and middle-income countries: variable progress towards an unfinished agenda
|
Victora, Cesar G
|
|
|
397 |
10282 |
p. 1388-1399
|
artikel
|
| 23 |
The CRISPR wars
|
Ball, Philip
|
|
|
397 |
10282 |
p. 1340-1341
|
artikel
|
| 24 |
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial
|
Marson, Anthony
|
|
|
397 |
10282 |
p. 1363-1374
|
artikel
|
| 25 |
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial
|
Marson, Anthony
|
|
|
397 |
10282 |
p. 1375-1386
|
artikel
|
| 26 |
The ultra-connected generation would like to disconnect now
|
Cassan, Julie
|
|
|
397 |
10282 |
p. 1350
|
artikel
|
| 27 |
The unsung virtue of thermostability
|
Capua, Ilaria
|
|
|
397 |
10282 |
p. 1346
|
artikel
|
| 28 |
Tigray atrocities compounded by lack of health care
|
Devi, Sharmila
|
|
|
397 |
10282 |
p. 1336
|
artikel
|
| 29 |
Triple jeopardy: disabled people and the COVID-19 pandemic
|
Shakespeare, Tom
|
|
|
397 |
10282 |
p. 1331-1333
|
artikel
|
| 30 |
WHO International Standard for anti-SARS-CoV-2 immunoglobulin
|
Kristiansen, Paul A
|
|
|
397 |
10282 |
p. 1347-1348
|
artikel
|
Tijdschrift beschrijving